We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+1.19%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$17.7B
AUM Growth
+$1.44B
(+8.9%)
Cap. Flow
+$1.58B
Cap. Flow
% of AUM
8.95%
Top 10 Holdings %
Top 10 Hldgs %
19.92%
Holding
1,403
New
439
Increased
358
Reduced
346
Closed
241
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$403M |
| 2 |
Walt Disney
DIS
|
+$157M |
| 3 |
CELG
Celgene Corp
CELG
|
+$141M |
| 4 |
Citigroup
C
|
+$137M |
| 5 |
Starbucks
SBUX
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$244M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$178M |
| 3 |
Canadian National Railway
CNI
|
+$146M |
| 4 |
AT&T
T
|
+$139M |
| 5 |
Micron Technology
MU
|
+$134M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.11% |
| 2 | Financials | 17.79% |
| 3 | Healthcare | 17.78% |
| 4 | Consumer Staples | 7.98% |
| 5 | Consumer Discretionary | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNBR
226
DELISTED
Sleep Number
SNBR
| $13M | 0.07% |
433,590
+289,068
| +200% | +$9.15M |
|
227
Murphy Oil
MUR
$4.74B
| $12.7M | 0.07% |
305,513
+291,413
| +2,067% | +$13.3M |
|
228
TechnipFMC
FTI
$27.3B
| $12.7M | 0.07% |
411,119
+162,355
| +65% | +$4.99M |
|
|
TTM
229
DELISTED
Tata Motors Limited
TTM
| $12.7M | 0.07% |
367,404
-163,336
| -31% | -$6.51M |
|
230
International Paper
IP
$21.5B
| $12.5M | 0.07% |
276,513
-93,280
| -25% | -$4.63M |
|
231
Constellation Brands
STZ
$22.6B
| $12.3M | 0.07% |
106,107
+90,507
| +580% | +$10.7M |
|
232
Yum! Brands
YUM
$41.6B
| $12.2M | 0.07% |
188,202
-108,575
| -37% | -$6.88M |
|
233
Cadence Design Systems
CDNS
$93.2B
| $12.1M | 0.07% |
617,049
+228,994
| +59% | +$4.44M |
|
|
AVNS
234
DELISTED
Avanos Medical
AVNS
| $12.1M | 0.07% |
297,579
-140,765
| -32% | -$6.32M |
|
|
PARA
235
DELISTED
Paramount Global Class B
PARA
| $12M | 0.07% |
+215,600
| New | +$13M |
|
236
Chubb
CB
$137B
| $11.9M | 0.07% |
+117,000
| New | +$12.6M |
|
237
World Acceptance Corp
WRLD
$886M
| $11.9M | 0.07% |
+193,043
| New | +$15.4M |
|
|
QGENF
238
DELISTED
QIAGEN NV
QGENF
| $11.8M | 0.07% |
477,118
+463,618
| +3,434% | +$11.5M |
|
|
ELP
239
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $11.8M | 0.07% |
2,674,530
+34,250
| +1% | +$152K |
|
|
CMO
240
DELISTED
Capstead Mortgage Corp.
CMO
| $11.6M | 0.07% |
1,043,172
+183,977
| +21% | +$2.17M |
|
241
Johnson Controls International
JCI
$93.6B
| $11.6M | 0.07% |
+223,183
| New | +$11.9M |
|
242
Scotiabank
BNS
$108B
| $11.5M | 0.06% |
+232,103
| New | +$11.8M |
|
243
BBVA Argentina
BBAR
$3.56B
| $11.4M | 0.06% |
720,278
-56,379
| -7% | -$1.04M |
|
244
Telefônica Brasil
VIV
$19.3B
| $11.4M | 0.06% |
+820,121
| New | +$12.2M |
|
245
Emergent Biosolutions
EBS
$272M
| $11.4M | 0.06% |
344,692
+112,638
| +49% | +$3.49M |
|
246
Bunge Global
BG
$20.9B
| $11.3M | 0.06% |
+129,224
| New | +$11.5M |
|
|
MTOR
247
DELISTED
MERITOR, Inc.
MTOR
| $11.3M | 0.06% |
864,768
+659,102
| +320% | +$8.84M |
|
248
Usana Health Sciences
USNA
$275M
| $11.3M | 0.06% |
164,726
+83,222
| +102% | +$5.28M |
|
249
Aon
AON
$76.5B
| $11.2M | 0.06% |
112,000
+95,000
| +559% | +$9.51M |
|
|
MBLY
250
DELISTED
Mobileye N.V.
MBLY
| $11M | 0.06% |
206,930
+78,372
| +61% | +$3.71M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2015 Portfolio in Review
As of Q2 2015, Arrowstreet Capital held 1,403 positions worth $17.7B, up 8.9% from $16.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Arrowstreet Capital deployed $1.58B of net new capital in Q2 2015, opening 439 new positions and adding to 358 existing holdings. Its largest new stake was Teva Pharmaceuticals: 1,922,584 shares worth $114M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Union Pacific, an estimated $244M trimmed.
- Arrowstreet Capital's largest Q2 2015 buy was Teva Pharmaceuticals: 1,922,584 shares worth $114M.
- Arrowstreet Capital added most to Apple in Q2 2015, an estimated $403M increase.
- Arrowstreet Capital's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $244M.
- Arrowstreet Capital fully exited Canadian National Railway in Q2 2015, selling an estimated $146M.
- Arrowstreet Capital's ten largest holdings make up 20% of its $17.7B portfolio in Q2 2015.
- Arrowstreet Capital opened 439 new positions and closed 241 in Q2 2015.
- Arrowstreet Capital's portfolio value rose 8.9% quarter-over-quarter to $17.7B.
Based on Arrowstreet Capital's 13F filing for Q2 2015, filed 13 Aug 2015.